Form 483

Laboratoires Delon Form 483, 2016-12-09

FDA issued a Form 483 to Laboratoires Delon on 2016-12-09 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Laboratoires Delon · Pointe-Claire, Canada · Issued December 9, 2016

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Dec 2016
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Samina S Khan

9 Dec 2016
21 CFR 211.170(b)

Annual visual exams of drug products

Cited by Samina S Khan

Inspected site

LDLaboratoires DelonPointe-Claire, Canada

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere